Home
/
Semnur Pharmaceuticals, Inc.
/
Financials
/
Quarterly
Semnur Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Semnur Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Oct 2, 2024
$50.00M
May 16, 2025
Q2
2025
Oct 2, 2024
$50.00M
Aug 15, 2025
Q3
2024
Feb 22, 2024
$50.00M
Nov 19, 2024
Q1
2024
Feb 22, 2024
$50.00M
May 22, 2024
Q2
2024
Feb 22, 2024
$50.00M
Aug 19, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($152.59M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($999.0K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($385.1K)
Aug 15, 2025
Q2
2025
Mar 31, 2025
($194.6K)
Aug 15, 2025
Q1
2025
Mar 31, 2025
($194.6K)
May 16, 2025
Q3
2025
Mar 31, 2025
($665.0K)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($1.30M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($1.11M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
$448.9K
Aug 15, 2025
Q1
2025
Mar 31, 2024
$264.3K
May 16, 2025
Q3
2025
Mar 31, 2024
($1.51M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
$264.3K
Aug 15, 2025
Q3
2024
Sep 30, 2023
$630.6K
Nov 19, 2024
Q2
2024
Jun 30, 2023
$457.7K
Aug 19, 2024
Q3
2024
Jun 30, 2023
$457.7K
Nov 19, 2024
Q3
2024
Mar 31, 2023
($1.01M)
Nov 19, 2024
Q2
2024
Mar 31, 2023
($1.01M)
Aug 19, 2024
Q1
2024
Mar 31, 2023
($1.01M)
May 22, 2024
Q3
2023
Sep 30, 2022
$307.5K
Nov 9, 2023
Q3
2023
Jun 30, 2022
($30.8K)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($152.59M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($374.9K)
Aug 15, 2025
Q1
2025
Mar 31, 2025
($246.6K)
May 16, 2025
Q3
2025
Sep 30, 2024
($1.30M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($168.2K)
Aug 15, 2025
Q1
2025
Mar 31, 2024
($368.3K)
May 16, 2025
Q3
2024
Sep 30, 2023
($505.9K)
Nov 19, 2024
Q2
2024
Jun 30, 2023
($563.7K)
Aug 19, 2024